Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency. (2016)
Attributed to:
Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2016.00314
PubMed Identifier: 27579027
Publication URI: http://europepmc.org/abstract/MED/27579027
Type: Journal Article/Review
Volume: 7
Parent Publication: Frontiers in immunology
ISSN: 1664-3224